Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Juno Therapeutics, Inc. (JUNO) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/01/2017 8-K Quarterly results
08/03/2017 8-K Quarterly results
Docs: "JUNO THERAPEUTICS REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS"
05/04/2017 8-K Form 8-K - Current report
11/09/2016 8-K Form 8-K - Current report
05/09/2016 8-K Form 8-K - Current report
11/10/2015 8-K Quarterly results
Docs: "JUNO THERAPEUTICS REPORTS THIRD QUARTER 2015 FINANCIAL RESULTS — Company-wide progress in advancing product candidates and building capabilities — — Conference call to be held today at 5:00pm Eastern Time"
08/12/2015 8-K Quarterly results
Docs: "JUNO THERAPEUTICS REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS — JCAR015 IND FDA clearance allows initiation of Juno's first pivotal trial — — Transformative partnership with Celgene — — Substantial R&D progress with key acquisition integrations on track — — Conference call to be held today at 5:00pm Eastern Time"
05/11/2015 8-K Quarterly results
Docs: "SHARE PURCHASE AGREEMENT related to PROJECT SPYDER",
"Juno Therapeutics Reports First Quarter 2015 Financial Results"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy